Search research articles
Contact Us
Filters
Showing results (1-10 of 5) with videos related to
Page
of 1
Sort By:
Clinical Hematology International
|
April 27, 2026
Should monitoring guidelines and decision to treat for IgM MGUS be different when caring for Jehovah's Witness patients?
Marshall Rosenberg, Alisha P Maity, Karthik Shankar, et al.
JCO Oncology Practice
|
June 15, 2023
Impact of Simultaneous Circulating Tumor DNA and Tissue Genotyping in the Workup of Stage IV Lung Adenocarcinoma on Quality of Care in an Academic Community Medical Center
Alisha P Maity, Mounika Gangireddy, Kathleen C Degen, et al.
Cancer Medicine
|
April 18, 2026
Prediction of Moderate to Severe Delayed Chemotherapy-Induced Nausea Using a Novel Algorithm Incorporating Individual Patient Factors
Alisha P Maity, Stephanie D Kjelstrom, Kathryn J Fleck, et al.
Oncoimmunology
|
March 1, 2021
A stratified phase I dose escalation trial of hypofractionated radiotherapy followed by ipilimumab in metastatic melanoma: long-term follow-up and final outcomes
Amit Maity, Rosemarie Mick, Ramesh Rengan, et al.
The Oncologist
|
May 15, 2023
A Phase II Open-Label Trial of Binimetinib and Hydroxychloroquine in Patients With Advanced KRAS-Mutant Non-Small Cell Lung Cancer
Charu Aggarwal, Alisha P Maity, Joshua M Bauml, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 5) with videos related to
Sort By:
Page
of 1
Clinical Hematology International
|
April 27, 2026
Should monitoring guidelines and decision to treat for IgM MGUS be different when caring for Jehovah's Witness patients?
Marshall Rosenberg, Alisha P Maity, Karthik Shankar, et al.
JCO Oncology Practice
|
June 15, 2023
Impact of Simultaneous Circulating Tumor DNA and Tissue Genotyping in the Workup of Stage IV Lung Adenocarcinoma on Quality of Care in an Academic Community Medical Center
Alisha P Maity, Mounika Gangireddy, Kathleen C Degen, et al.
Cancer Medicine
|
April 18, 2026
Prediction of Moderate to Severe Delayed Chemotherapy-Induced Nausea Using a Novel Algorithm Incorporating Individual Patient Factors
Alisha P Maity, Stephanie D Kjelstrom, Kathryn J Fleck, et al.
Oncoimmunology
|
March 1, 2021
A stratified phase I dose escalation trial of hypofractionated radiotherapy followed by ipilimumab in metastatic melanoma: long-term follow-up and final outcomes
Amit Maity, Rosemarie Mick, Ramesh Rengan, et al.
The Oncologist
|
May 15, 2023
A Phase II Open-Label Trial of Binimetinib and Hydroxychloroquine in Patients With Advanced KRAS-Mutant Non-Small Cell Lung Cancer
Charu Aggarwal, Alisha P Maity, Joshua M Bauml, et al.
Page
of 1